Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | Lestaurtinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | IL-4 | 21.5 | 42 | |
RA2159 | Ruxolitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | IL-4 | 17.0 | 57 | |
RA2159 | Tofacitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | IL-4 | 21.5 | 34 | |
RA2159 | IKK16 | 2.0 | uM | Visfatin | 1 | ng/mL | 1 | IL-4 | 17.0 | 53 | |
N2586 | Visfatin | 1 | ng/mL | 1 | IL-4 | 20.5 | 42 | ||||
N2586 | PD184352 | 0.1 | uM | Visfatin | 1 | ng/mL | 1 | IL-4 | 20.0 | 51 | |
N2586 | Lestaurtinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | IL-4 | 23.0 | 46 | |
N2586 | Ruxolitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | IL-4 | 19.0 | 49 | |
N2586 | Tofacitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 1 | IL-4 | 17.5 | 42 | |
N2586 | IKK16 | 2.0 | uM | Visfatin | 1 | ng/mL | 1 | IL-4 | 23.0 | 24 | |
0 | IL-4 | 19.0 | 46 | ||||||||
RA2159 | Poly(I:C) | 2 | ug/mL | 1 | IL-4 | 39.0 | 53 | ||||
RA2159 | PD184352 | 0.1 | uM | Poly(I:C) | 2 | ug/mL | 1 | IL-4 | 29.5 | 42 | |
RA2159 | Lestaurtinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | IL-4 | 22.0 | 58 | |
RA2159 | Ruxolitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | IL-4 | 27.0 | 38 | |
RA2159 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | IL-4 | 33.0 | 63 | |
RA2159 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 1 | IL-4 | 24.0 | 55 | |
N2586 | Poly(I:C) | 2 | ug/mL | 1 | IL-4 | 41.5 | 38 | ||||
N2586 | PD184352 | 0.1 | uM | Poly(I:C) | 2 | ug/mL | 1 | IL-4 | 33.0 | 54 | |
N2586 | Lestaurtinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | IL-4 | 22.0 | 51 | |
N2586 | Ruxolitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | IL-4 | 28.0 | 22 | |
N2586 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 1 | IL-4 | 39.5 | 38 | |
N2586 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 1 | IL-4 | 26.0 | 30 | |
0 | IL-4 | 22.0 | 45 | ||||||||
RA2159 | 2 | IL-4 | 21.0 | 57 |